These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 11505748

  • 21. [Immunosuppressive therapies in patients with Graves' ophthalmopathy].
    Wang J, Wang YT, Shao JQ, Wang X, Du H.
    Zhonghua Nei Ke Za Zhi; 2004 Feb; 43(2):125-7. PubMed ID: 15059413
    [Abstract] [Full Text] [Related]

  • 22. [Prediction for effectiveness of steroid pulse therapy by MRI in Graves' ophthalmopathy].
    Sato M, Hiromatsu Y, Tanaka K, Nonaka K, Kojima K, Nishimura H, Nishida H.
    Nihon Naibunpi Gakkai Zasshi; 1992 Mar 20; 68(3):143-53. PubMed ID: 1582520
    [Abstract] [Full Text] [Related]

  • 23. [Serum Fas in patients with Graves' ophthalmopathy as a marker of activity of the ocular inflammatory infiltration].
    Myśliwiec J, Kretowski A, Stepień A, Okłota M, Kinalska I.
    Pol Merkur Lekarski; 2004 Oct 20; 17(100):368-70. PubMed ID: 15690704
    [Abstract] [Full Text] [Related]

  • 24. Quality of life assessment in patients with Graves' disease and progressive infiltrative ophthalmopathy during combined treatment with methylprednisolone and orbital radiotherapy.
    Kulig G, Andrysiak-Mamos E, Sowińska-Przepiera E, Kulig J, Karakiewicz B, Brodowski J, Robaczyk M, Homa K, Letkiewicz M, Syrenicz A.
    Endokrynol Pol; 2009 Oct 20; 60(3):158-65. PubMed ID: 19569015
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathy.
    De Bellis A, Sansone D, Coronella C, Conte M, Iorio S, Perrino S, Battaglia M, Bellastella G, Wall JR, Bellastella A, Bizzarro A.
    Clin Endocrinol (Oxf); 2005 Jan 20; 62(1):24-9. PubMed ID: 15638866
    [Abstract] [Full Text] [Related]

  • 34. Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study.
    Salvi M, Vannucchi G, Campi I, Currò N, Dazzi D, Simonetta S, Bonara P, Rossi S, Sina C, Guastella C, Ratiglia R, Beck-Peccoz P.
    Eur J Endocrinol; 2007 Jan 20; 156(1):33-40. PubMed ID: 17218723
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.